Make us your home page

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Prostate cancer studies' conflicting results muddle debate

NEW YORK — Two big, long-awaited prostate cancer studies published Wednesday found that screening for the disease may save a few lives, but at a high price. The findings are unlikely to end the debate over the usefulness of routine testing for the most common cancer in men.

The two studies — one in Europe and one in the United States — reached different conclusions. In the United States, where screening is widely used, researchers reported it did not save lives in a study of 76,000 men. In Europe, where the practice isn't routine, a study of 162,000 found a modest reduction — about 7 fewer deaths per 10,000 men screened. But that screening put more men at risk of getting treatments they didn't need.

The studies are continuing and may eventually provide more definitive answers, researchers said.

In the meantime, experts say men should do what most guidelines advise: Talk to your doctor about the pros and cons of having the tests before deciding whether it is the right choice for you.

The studies were released Wednesday by the New England Journal of Medicine in connection with a conference in Sweden.

"The hope was there that there'd be a clear answer. Either that there was so little or no benefit that it clearly wasn't worth the risks. Or that the benefit was so large, that it was," said Dr. Michael Barry of Massachusetts General Hospital, who wrote an accompanying editorial in the journal. "What we're left with is something in between — that the benefit is fairly small . . . and the risks are pretty big."

Prostate cancer is the most common cancer in men in the United States and Europe. More than 186,000 cases will be diagnosed this year in American men and 28,660 will die of the disease.

Screening is done with a blood test that measures prostate specific antigen, or PSA. Levels of PSA can be high for many reasons and a biopsy is needed to confirm a tumor. Many tumors grow so slowly that they won't be a threat, but there's no sure way to tell which are the dangerous ones.

And there's no agreement on the best treatment approach — "watchful waiting," surgery, hormone therapy or radiation. The treatments can lead to impotence and incontinence.

Both groups are reporting their results a few years early. In the United States, a panel monitoring the research decided there was enough evidence so far that screening wasn't saving lives and may have been leading to unnecessary treatment with serious side effects.

That study involved 76,693 men ages 55 to 74 from 10 cities. After seven to 10 years of followup, more cases of prostate cancer were found in the group that got annual screening, but there was no difference between the groups in the number of cancer deaths. The researchers plan to follow all the men for at least 13 years.

What's needed, the researchers said, is a better way to tell which prostate cancers need to be treated.

"When we find prostate cancer, we don't know if it is a killer cancer or what has been termed a toothless lion — the kind of cancer that men will die with, not of," said the U.S. study's leader, Dr. Gerald Andriole of Washington University School of Medicine in St. Louis.

Prostate cancer studies' conflicting results muddle debate 03/18/09 [Last modified: Wednesday, March 18, 2009 6:48pm]
Photo reprints | Article reprints

Copyright: For copyright information, please check with the distributor of this item, Associated Press.

Join the discussion: Click to view comments, add yours

  1. Forecast: Sunny skies, warm temperatures to rule across Tampa Bay this week


    After periods of heavy rain in some parts of Tampa Bay over the weekend, the region can expect sunny skies, and warm condition to prevail through the workweek.

    [10Weather WTSP]
  2. PolitiFact Florida: How would Florida fare in Graham-Cassidy health care bill?


    Following a sharp rebuke by late-night talk show host Jimmy Kimmel, Sen. Bill Cassidy, R-La., hit the airwaves to defend his bill that would undo much of the Affordable Care Act.

    Sen. Bill Cassidy, R-La.
  3. Whatever happened to the Zika epidemic?


    Remember Zika?

    The last time Gov. Rick Scott warned Floridians about the potential threat of the mosquito-borne virus was in July, when he urged residents to still be vigilant against bug bites and standing water. At the time, doctors and researchers were bracing for what was supposed to be another active summer …

    Aedes aegypti mosquitoes are responsible for transmitting Zika. Cases of the virus are down dramatically in Florida.
  4. Pinellas licensing board needs cash. Will the county give it any?

    Local Government

    LARGO –– The grand jury that said Pinellas County should not take over the troubled construction licensing board also said the county should bail out the agency before it goes broke in 2018.

    Pinellas County Commission chair Janet Long isn't keen on the idea of the county loaning money to keep the Pinellas County Construction Licensing Board afloat. The county has no say over the independent agency, which could run out of funding in 2018. [SCOTT KEELER   |   Times]
  5. Is the Bundt cake back? How retro baked goods are becoming trendy again


    Once there were grunts and slumps, buckles and brown betties. Oh, and pandowdies and sonkers. In the olden days, people routinely made angel food cakes, tomato soup cakes and hummingbird cakes. These were not Duncan Hines mixes, but rather confections made from scratch following yellowed and stained recipes in your …

    Nothing Bundt Cakes in Tampa offers a variety of options, from tiny “bundtinis” and 10-inch cakes that serve 18 to 20 people. Core flavors include lemon, marble, red velvet and chocolate-chocolate chip, with featured flavors like confetti.